Osteologický bulletin, 2008 (vol. 13), issue 1

Of women, men and bonesReview articles

J. Jenšovský

Clin Osteol 2008; 13(1): 3

Quantitative and qualitative parameters of the male skeleton in relation to hormonal homeostasisReview articles

I. Žofková

Clin Osteol 2008; 13(1): 4-7

Should male obesity be considered as one of risk factors of osteoporotic fracture?Short communications

P. Řehořková, V. Palička, P Živný

Clin Osteol 2008; 13(1): 9-11

Tibolone in the prevention and treatment of postmenopausal osteoporosisShort communications

J. Vokrouhlická

Clin Osteol 2008; 13(1): 12-16

For over 20 years, tibolone has been used for the treatment of vasomotor symptoms and for the prevention of osteoporosis in postme­ nopausal women. Thanks to its unique, tissue-specific metabolism, it was included in the group of selective tissue estrogenic activity regulators (STEARs). Tibolone decreases bone turnover to an extent similar to that in hormonal therapy and increases bone mineral density in both younger and older postmenopausal women. This was confirmed by a large clinical study that informed about statisti­ cally significant reduction in the risk of new vertebral fractures in elderly osteoporotic women treated with a daily dose of 1.25...

Chronic pancreatitis and metabolic osteopathiesNews

H. Dujsíková, P. Dítě, J. Tomandl, A. Ševčíková, M. Mišejková, M. Pfiecechtělová

Clin Osteol 2008; 13(1): 17-22

Chronic pancreatitis is an inflammatory disease manifested by maldigestion and in an advanced stage by malabsorption. The aim of our research was monitoring the occurrence of metabolic osteopathies (osteopenia, osteoporosis and osteomalacia ) in patients with chronic pancreatitis. The group consisted of 73 patients (17 women a 56 men) in different stage of chronic pancreatitis. In all patients were determined serum concentrations of Ca, P, 25-OH vitamin D, 1,25 (OH)2 vitamin D, alkaline phosphatase and its bone izoen­ zym. Bone mineral density was measured by dual - energy X- ray absorptiometry (DXA) in lumbar spine (L1-L4) and in proximal femur. In...

Calibration of DXA machines in the Czech Republic - pilot project of SMOSCase reports

Petr Kasalický

Clin Osteol 2008; 13(1): 23-25

IOF Osteoporosis Diagnosis Course with Densitometry Certification Luhačovice 27.-28. 10. 2007News

Clin Osteol 2008; 13(1): 26-27

The NEW IOF One-Minute Osteoporosis Risk TestInformations

Clin Osteol 2008; 13(1): 28

Osteology Centre České BudějoviceInformations

I. Kučerová

Clin Osteol 2008; 13(1): 30

Report from the 29th ASBMR meeting, Honolulu, Hawaii, 16.-19. 9. 2007News

T. Hála, F. Šenk

Clin Osteol 2008; 13(1): 31

Wod Report SlovakiaInformations

Clin Osteol 2008; 13(1): 32-33

News from around the worldLiterature

Clin Osteol 2008; 13(1): 34-36
Share...

Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

No
Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.